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Introduction: The aim of the article was to report on the long-term follow-up of choroidal 
neovascularization (CNV) cases secondary to punctate inner choroidopathy (PIC) either treated 
with photodynamic therapy (PDT) or followed without treatment. A comprehensive review of 
existing literature on the various treatment modalities is incorporated.
Methods: Nine eyes of 8 female patients with CNV due to PIC were followed retrospectively 
for an average of 105 months (range, 36–162 months). Mean age of the patient cohort on pre-
sentation was 28 years (range, 21–39). Four eyes were treated with PDT, whereas in 4 patients, 
including 1 with bilateral involvement, the disease followed its natural course without treatment. 
Snellen visual acuity and the extent of neovascularization and subretinal fibrosis were evaluated 
on presentation and at the end of the follow-up period.
Results: Improvement of vision was observed in 6 eyes (66.7%), including all cases treated 
with PDT, and in 2 of 5 eyes left untreated. The size of the neovascular lesion, including both 
CNV and subretinal fibrosis, increased in all cases left untreated (55.6%) and remained stable 
in all cases treated with PDT (44.4%).
Conclusion: Without treatment, the CNV due to PIC is slowly progressive. Our short cohort 
appears to have benefited from PDT in terms of maintaining visual acuity and stabilizing the 
extent of CNV and fibrosis.
Keywords: PIC natural course, PIC treatment
Introduction
Punctate inner choroidopathy (PIC) is an inflammatory chorioretinal disease of 
unknown etiology, first described by Watzke et al in 1984.1 It presents mostly in 
healthy, young, moderately myopic women2 with metamorphopsia and decreased 
visual acuity. On fundoscopy, small, creamy, yellow-white lesions, measuring 
100–300 µm, located in the retinal pigment epithelium and inner choroid without 
concomitant intraocular inflammation are the hallmark of the early disease.2 The optic 
nerve head can be mildly swollen.3 Fluorescein angiography (FA) reveals areas with 
early   hyperfluorescence and late leakage,3 whereas, remarkably, on indocyanine green 
angiography, more   hypofluorescent spots than observed clinically or on FA are   evident, 
with normal large choroidal vessels running through the hypofluorescent areas.3,4 
At least 25%–40% of patients develop choroidal neovascularization (CNV), usually 
within the first 6 months, although CNV may occur years after the initial lesions. For 
the remaining 60%–75%, the visual prognosis is rather favorable with the majority 
of eyes retaining vision of 20/30 or better.2,4,5Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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The variety of treatment options for the CNV in PIC 
reflects the puzzling absence of consistent results and 
includes submacular surgery,6,7 steroids,4,8,9 photodynamic 
therapy (PDT),10–16 and most recently anti-VEGF agents.17,18 
In cases of extrafoveal or juxtafoveal lesion, CNV laser 
photocoagulation can also be attempted.4 We report on the 
long-term outcome of a cohort of young adults with PIC 
complicated with CNV who either underwent PDT or left 
to follow the natural course of the disease.
Patients and methods
The charts of patients with a definite diagnosis of PIC from 
September 1993 were identified and reviewed. A total 
of 9 eyes of 8 patients with actively leaking CNV were 
included in the study and retrospectively followed for a 
total of 36–162 months (average, 105 months). In 1 patient, 
there was bilateral involvement, whereas in 7 patients, the 
CNV was unilateral. Four eyes were treated with PDT, and 
5 eyes were left untreated. The latter was considered an estab-
lished treatment modality for CNV , before the introduction 
of PDT. The patient who suffered bilateral involvement was 
also administered interferon-2b (IFN-2b; 3 MU subcutane-
ously 3 times per week) for viral hepatitis-B diagnosed dur-
ing the initial workup, and 1 patient had been treated with 
thermal laser prior to PDT (Table 1).
Treatment with PDT followed the standard protocol 
and consisted of an intravenous infusion of 6 mg/m2 verte-
porfin (Visudyne; Novartis AG, Bülach, Switzerland) 
for 10 minutes. Fifteen minutes after the initiation of the 
infusion, the photosensitizer was activated using a laser 
light of 689 nm delivered at 50 J/cm2 with an intensity of 
600 mW/cm2 for 83 seconds. The treatment spot was set to 
cover the   greatest linear dimension of the CNV lesion, with 
an additional 500 µm covering the borders on each side. 
FA was performed prior to PDT to evaluate the extent of 
CNV and repeated during follow-up to evaluate the CNV 
activity. Retreatment was considered in cases of residual 
leakage or reactivation.
Studied parameters included Snellen visual acuity and the 
extent of active neovascularization and subretinal fibrosis, 
as evaluated by reviewing the FA on presentation and at the 
end of follow-up period. Patient demographics, treatment, 
and final results are summarized in Table 1.
Results
report of selected cases
Patient 1
A 36-year-old female myopic patient was initially referred 
in June 2001 with a right-sided visual impairment of 
6-weeks duration. On presentation, best-corrected visual 
acuity (BCVA) amounted to 20/400 OD (ocular dexter) and 
20/20 OS (ocular sinister) with a corresponding refractive 
error of −4.0D and −2.5D. Fundus examination revealed 
  several scattered chorioretinal scars on the posterior pole 
of the affected eye and an extensive submacular exuda-
tive lesion, which angiographically corresponded to CNV 
 ( Figure 1A). PIC complicated with subfoveal CNV was 
  diagnosed. The patient underwent standard PDT with a 
4,200-µm spot size on July 2001, repeated once on Febru-
ary 2002. Three months following the second PDT session, 
BCVA had improved to 20/100 OD. Visual acuity remained 
stable during the follow-up period, whereas on FA a central 
chorioretinal scar without signs of leakage was evident 
(Figure 1B).
Table 1 Patient demographics, refraction, and clinical course
Patient no. Age at 
presentation
Gender Eye Refraction Initial VAa Treatment  
(sessions)
Follow-up  
(months)
Final VAa CNV-subretinal 
fibrosis extentb
1 36 F OD −4.0 20/400 PDT (2) 72 20/100 stable
2 21 F Os −3.75 to 0.75 × 20 20/400 PDT (2) 36 20/25 stable
3 35 F Os −3.0 to 0.5 × 180 20/400 none 124 20/800 increased
4 29 F Os −2.5 20/80 none 126 20/40 increased
5 22 F OD −2.0 20/25 none 159 20/50 increased
– – – Os −3.0 20/40 none 162 20/100 increased
6 24 F OD −3.0 to 0.75 × 115 20/70 none 134 20/30 increased
7 39 F Os −1.75 to 0.75 × 90 20/50 PDT (1) 48 20/30 stable
8 21 F OD −3.0 to 0.75 × 60 20/70 Thermal laser  
or PDT (2)
84 20/25 stable
Average 28 – – – – – 105.0 – –
Notes: asnellen. bCompared with lesion extent on presentation.
Abbreviations: VA, visual acuity; CnV, choroidal neovascularization; OD, oculus dexter; Os, oculus sinister; PDT, photodynamic therapy.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Patient 2
A 21-year-old female myopic patient was initially referred in 
June 2004 with a 2-month history of floaters and decrease of 
vision from the left eye. Her refractive error was OD −4.5 D 
and OS −3.75 to 0.75 × 20, and on presentation, BCVA was 
20/20 and 20/400, respectively. A typical picture of left-sided 
PIC complicated with CNV was evident on fundoscopy 
and FA. Upon diagnosis, the patient was treated with PDT 
with a 4,100-µm spot size. One month later, visual acuity had 
improved to 20/100 OS, but due to persistence of fluorescein 
leakage, the patient was retreated with PDT. In December 
2004, visual acuity had improved to 20/30 OS, whereas 
the CNV remained angiographically inactive. At the end 
of a 3-year follow-up period, the visual acuity amounted to 
20/25 OS without leakage on FA.
Patient 3
A 35-year-old female myopic patient was referred in 
  October 1996 with decreased vision and   metamorphopsia 
in her left eye of 3 weeks duration. Myopic error was 
OD −4.0 D and OS −3.0 to 0.5 × 180 with a BCVA of 20/40 
and 20/400, respectively. She reported an episode of central 
serous chorioretinopathy in her right eye 9 years earlier. 
Based on fundoscopy and FA findings, PIC complicated with 
subfoveal CNV was diagnosed. None of the treatment options 
was deemed effective at that time, and the disease was left 
to follow its natural course. Three months later, her visual 
acuity improved to 20/80 OS but subsequently deteriorated 
to less than 20/400 in July 1997. On FA, a large neovascular 
membrane was evident, which eventually progressed to an 
extensive disciform chorioretinal scar.
Patient 5
A 22-year-old female myopic patient was initially referred in 
September 1993 with left eye visual impairment and meta-
morphopsia. Refractive error was OD  −2.0 D and OS −2.5 D 
with a corresponding BCVA of 20/25 OD and 20/40 OS on 
Snellen optotype. A left eye subfoveal CNV was evident 
on FA. On general workup, active hepatitis B was diagnosed, 
and  α-IFN-2b (3MU subcutaneously 3 times per week) 
was administered immediately until   February 1994. Three 
months after her referral, although she was on the IFN 
treatment, she developed CNV in the right eye along with 
several discrete chorioretinal small scars with diameter of 
approximately 200–300 µm mainly around the optic disc. On 
February 1996, her visual acuity was 20/50 in the right eye 
and 20/100 in the left eye, which was stable in all consecutive 
follow-up examinations. Subsequent FAs confirmed the pres-
ence of chrorioretinal scars without leakage bilaterally.
Patient 6
A 24-year-old female myopic patient ([OD  −3.0 to 0.75 × 115] 
and [OS −4.0 D]) was initially referred in December 1995 with 
right eye visual impairment and metamorphopsia. BCVA on 
presentation was 20/70 OD and 20/25 OS. Fundus examina-
tion revealed a small exudative lesion that was leaking on FA 
in the right eye (Figure 2A) and several creamy, yellow-white 
lesions in the left eye with faint staining in the late phases 
of FA. None of the current treatment options was deemed 
effective, and the disease was left to follow its natural course. 
Three years later, an increase of the size of CNV was noted 
on FA, although visual acuity had improved to 20/30 OD. 
In subsequent follow-ups, visual acuity remained stable.   
Figure  1  Case  1.  Choroidal  neovascularization  with  photodynamic  therapy 
treatment. A) On presentation. B) At the end of 72-month follow-up period. The 
choroidal neovascularization is stable.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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On her last visit 11 years after the diagnosis of PIC, visual 
  acuity was 20/30 in the right eye and 20/25 in the left eye, 
the FA showed juxtafoveal lesions with staining but without 
leakage in the right eye (Figure 2A) and some scattered cho-
rioretinal slightly pigmented small lesion in the left eye.
Nine eyes of 8 female patients were retrospectively 
  followed for an average of 105 months (range, 36–162 months) 
after the diagnosis of PIC associated with active CNV. 
Mean age of the patient group was 28 years (range, 21–39). 
Four eyes were initially treated with PDT, in 3 of which the 
treatment was repeated once due to active leakage on sub-
sequent FA. The remaining 5 eyes were followed without 
treatment mainly due to the lack of a widely accepted effec-
tive treatment at the time of presentation.
Visual acuity on presentation measured 20/40 or better 
in 2 eyes (22.2%), ranged from 20/40 to 20/200 in 4 eyes 
(44.4%), and was 20/200 or worse in 3 eyes (33.3%). 
Improvement of vision was noted in 6 eyes at the end of the 
follow-up period (66.7%), including all cases treated with 
PDT, and in 2 of 5 eyes left untreated, and visual acuity 
deterioration was noted in 3 eyes (33.3%).
The size of the neovascular lesion, including both CNV 
and subretinal fibrosis, increased in 5 eyes (55.6%) and was 
stable in 4 eyes (44.4%) all treated with PDT. A trend toward 
better final visual acuity and stability of CNV activity was 
identified in the subgroup receiving PDT.
Discussion
The management of CNV due to PIC has not been conclu-
sively determined, as most published cohorts (Table 2) report 
on small number of patients with short follow-up, includ-
ing some with intermixed subfoveal and juxtafoveal CNV 
lesions. A variety of treatment options have been described, 
including PDT,10–16 use of local and systemic steroid 
monotherapy,2,4,9 submacular surgery,6,7 and recently anti-
VEGF agents.17,18 Corticosteroids have also been advocated 
as a therapeutic adjunct to PDT, in particular due to their dual 
anti-inflammatory and antiangiogenetic properties.19,20
Oral steroids and laser photocoagulation were tried as 
early as 1984 by Watzke et al1 in their initial presentation of 
10 cases of a clinical entity that they termed “PIC”. Brown 
et al2 presented 5 patients who underwent oral and subtenon 
corticosteroid treatments, which reportedly slowed or stopped 
the subfoveal neovascularization, though without effect on 
final visual acuity which was less than 20/200 in all eyes. 
Submacular surgery was considered as a potential treatment 
of CNV due to PIC in 1995 by Adelberg et al,7 who reported 
1 case with more than 2 lines of Snellen acuity gain at the 
end of the follow-up period. Olsen et al6 in 1996 reported 
further promising results in 5 patients (6 eyes) who underwent 
submacular surgery and noted visual improvement in all 
6 eyes, although recurrences were common (4 out of 6 eyes). 
Sickenberg et al11 in 2000 presented 1 case treated with PDT 
and followed for 35 weeks with no change in visual acuity 
(20/100), whereas Rogers et al10 reported on 6 cases of PIC 
complicated with CNV and treated with PDT, and noted 
visual improvement in 4 eyes, decline in 1 and, stabilization 
in 1. Further reports on small cohorts of patients with PIC by 
Wachtlin et al,12 Chatterjee and Gibson,13 Postelmans et al,14 
Lim et al,15 and Coco et al16 substantiate a general trend 
toward favorable results with PDT. Fong et al21 and Chan 
et al22 reported encouraging results on combined PDT with 
oral or intravitreal steroid. Finally, Vossmerbaeumer et al17 
reported the successful outcome in a case of CNV secondary 
to PIC with intravitreal anti-VEGF treatment (bevacizumab), 
Figure  2  Case  6.  Choroidal  neovascularization  without  photodynamic  therapy 
treatment. A) On presentation. B) At the end of 134-month follow-up period. 
There is an apparent increase of choroidal neovascularization.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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and Leung et al18 reported favorable results in a case with 
intravitreal ranibizumab after a short-term follow-up.
PDT is generally safe and effective for subfoveal CNV in 
age-related macular degeneration and high myopia. For other 
CNV etiologies, PDT is an option if outcome without treat-
ment is likely to be poor, and preliminary success in ocular 
histoplasmosis syndrome, angioid streaks, idiopathic, and 
other conditions has been reported.10,11 Our results correlate 
with the ones reported by other authors11–16 further substan-
tiating PDT as an effective treatment option in CNV due to 
PIC. It also adds to relevant literature a small but significant 
cohort of patients with long-term follow-up, which highlights 
the prolonged effectiveness of PDT in this patient group. The 
natural course of the disease is also demonstrated in our study 
with the presentation of a number of patients left untreated. 
Some of this group retained a functional visual acuity even 
after a long follow-up, implying that active neovascularization 
may recede leaving macula relatively unharmed.
Allowing for obvious limitations, such as the small num-
ber of cases and the retrospective review of patient records, 
our study contributes mainly with the long-term follow-up to 
the limited body of literature regarding CNV due to PIC.
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